Institut d'Investigació Sanitària Illes Balears (IdISBa) Research Group.

Tag: MALDI-TOF

O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection of high-risk clones.

Mulet X1, García R1, Gayá M1, and Oliver A1 1Hospital Universitario Son Espases,Palma de Mallorca,Spain. Abstract: The increasing prevalence of extensively drug-resistant (XDR) Pseudomonas aeruginosa infections is due to the global spread of defined high-risk clones (HRC). Among them, ST175 is particularly frequent in Spain and France. Here, we evaluated O-antigen serotyping and MALDI-TOF as… Read More ›

ARPBIG IdISBa

Dr. Bartolome Moyà

Instituto de Investigación Sanitaria Illes Balears